Top Synthetic Biology Companies in Norway

The company, Syngens, specializes in synthetic biology by utilizing a diverse range of bacterial cell factories and extending its platform to higher eukaryotes. Their AI-powered approach to DNA design enhances biomanufacturing efficiency and sustainability.

ClexBio is a regenerative medicine company focused on innovative tissue engineering, utilizing advanced microfluidics and proprietary hydrogel technology to create scalable, high-throughput tissue generation solutions. Their approach emphasizes enabling biological processes rather than replacing them, which aligns with the principles of synthetic biology.

ArcticZymes Technologies specializes in enzymatic solutions that are crucial for advancements in molecular research, diagnostics, and therapeutics. With over 30 years of experience, the company emphasizes customized enzyme development, ensuring high quality and consistency that can significantly enhance research and biopharmaceutical manufacturing processes.

PubGene AS specializes in bioinformatics solutions, developing tools that enhance the organization of information in the life sciences, including applications for microarray techniques. Their Coremine platform creates domain-specific portals that may be valuable for advancing knowledge in synthetic biology and personalized medicine.

Vitroscope is focused on advancing synthetic biology through its AI-native technologies that enhance early-stage clinical research and offer alternatives to animal testing. Their ongoing collaborations and innovations in live imaging and perfusion measurement are key to developing high-accuracy data flows in life sciences.

Biolink Group is focused on developing novel industrial applications using biologically active anthocyanins, showcasing their expertise in biotech R&D since the 1980s. Their modern laboratories and pilot production plant support innovative advancements in the field.

Photosynthetic, a brand by Rift Labs, is dedicated to advancing plant research and innovation through tailored dynamic lighting that enhances yields. Their commitment to sustainable food production aligns with the principles of synthetic biology, emphasizing the importance of science and technology in agriculture.

In-Virtualis is focused on revolutionizing molecular modeling and simulation, particularly for applications in drug discovery and vaccine development. Their next-generation Computer Aided Molecular Design (CAMD) workstation aims to enhance the efficiency and precision of these processes, making advanced technologies more accessible and affordable.

Genetic Analysis AS is a pioneering diagnostic company in the human microbiome field, having developed the GA-map® Dysbiosis Test Lx, the first CE-marked in vitro diagnostic test for identifying dysbiosis in IBS and IBD patients. With over a decade of research and expertise, the company focuses on innovative solutions for the growing microbiome market.

The Oslo Cancer Cluster Incubator fosters a dynamic environment for scientists and start-ups, including Oncosyne, a biotech company focused on developing a platform for clinical-grade in vitro diagnostic drug screening. This support system enhances opportunities for innovation and collaboration in the life sciences sector.